FDA, Markets
FDA Approves Johnson & Johnson's Imaavy for gMG Treatment
33% center coverage3 sources
FDA
Top News
First 100 Days
See how you scored in predicting Trump's first 100 days
Latest News
FDA, Consumer Alerts
Upper Crust Bakery Recalls 818 Cases of Bread Due to Glass Fragments in Six States
50% center coverage2 sources
FDA, Consumer Alerts
Upper Crust Bakery Recalls 818 Cases of Bread Due to Glass Fragments in Six States
50% center coverage2 sources
FDA, Markets
FDA Delays Aficamten Approval Review to December 26
50% center coverage2 sources
FDA, Markets
FDA Delays Aficamten Approval Review to December 26
50% center coverage2 sources
FDA
Neuralink to Begin Human Trials on Speech Device
33% center coverage3 sources
FDA
Neuralink to Begin Human Trials on Speech Device
33% center coverage3 sources
FDA
FDA Approves Sapien 3 TAVR for Asymptomatic Severe Aortic Stenosis
100% left coverage1 source
FDA
FDA Approves Sapien 3 TAVR for Asymptomatic Severe Aortic Stenosis
100% left coverage1 source
FDA, Stocks
FDA Approves Edwards' TAVR for Asymptomatic Aortic Stenosis
100% left coverage1 source
FDA, Stocks
FDA Approves Edwards' TAVR for Asymptomatic Aortic Stenosis
100% left coverage1 source
FDA
FDA Grants RMAT Designation to 4D-150 for Diabetic Macular Edema
100% left coverage1 source
FDA
FDA Grants RMAT Designation to 4D-150 for Diabetic Macular Edema
100% left coverage1 source
FDA
FDA Approves Nipocalimab for Generalized Myasthenia Gravis Treatment
100% left coverage1 source
FDA
FDA Approves Nipocalimab for Generalized Myasthenia Gravis Treatment
100% left coverage1 source
First 100 Days
See how you scored in predicting Trump's first 100 days
Most Reported By
News from FDA
News from FDA